Jonathan Sheffi is cofounder of Curoverse, an early-stage startup building a platform for storing and processing genomic and biomedical big data. Based on the Arvados open source project, Curoverse will be the basis for precision medicine applications addressing everything from neonatal screening to cancer diagnosis and treatment.
Before cofounding Curoverse, Jonathan spent several years in the biotech industry, including roles with Novartis Diagnostics, Amgen, and Accenture's Health and Life Sciences Strategy practice. He holds an MBA from Harvard Business School, an MEng focused in computational molecular biology from MIT, and undergraduate degrees in mathematics & computer science, also from MIT. In 2007, he graduated from National Bartenders School.
Hello from Boston, and from the 2012 Partners Personalized Medicine Conference, which last week brought together life science thought leaders from business, research and technology. Several themes that emerged from... Read more »
Good morning from Mountain View, CA, and from the close of the 2012 Personalized Medicine World Conference, which brought together thought leaders of business, government, healthcare-delivery, research and technology. Four themes... Read more »